Prepared for Michael B. | Delivered January 2, 2020
SWOT Analysis Bristol-Myers Squibb
Review your project details
For a communication plan, a SWOT analysis of Bristol-Myers Squibb is needed.
provides a SWOT analysis of Bristol-Myers Squibb (BMS). While only a brief description is given of the strengths and opportunities, the weaknesses and threats are given more substance.
that provides a SWOT analysis of Bristol-Myers Squibb.
Both reports highlight the company's
strength in product innovation
and that it has a
successful track record
in developing new products and innovating products.
Both reports highlight BMS's
strong brand portfolio
and that the company has worked hard in
building this portfolio
Other strengths regard its finances as the company has a
on capital expenditure, a strong free cash flow, and its
high credit rating
and low borrowing cost. Also, the automation of activities, high customer satisfaction and successful integration of complimentary firms through mergers and acquisitions are mentioned.
revenue depends on a few brands
(Opdivo, Sprycel, Yervoy, and Baraclude). In 2017, these drugs made up 80% of revenue and in 2018
88% of revenue
. The focus is on these few brands and therefore its portfolio lacks differentiation.
Biologics has innovated the treatment of chronic illnesses and competitors are heavily investing in this area. Though BMS is investing in this area and will
continue to increase
its investments in its biologics manufacturing capabilities, the company has
a weak presence
in the biologics segment. BMS is not in the
top 5 companies
ranked according to biologics sales and its products are not included in the
top 10 biologics brands
With regard to research and development (R&D), the reports differ in opinion as one report mentions that there is a strong focus on R&D and the other mentions that it invests less than the fastest growing players in the industry and is therefore unable to compete with key players. In 2018, BMS spent
on R&D while Roche (a competitor) spent
CHF 11,047 million
Summary of Findings
During the initial hour of research, we focused on finding SWOT analysis for BMS.
We were able to find 2 reports and the strengths and some weaknesses mentioned in these reports were mentioned in the early findings. While it was not possible to mention the opportunities and threats to the company, these have been mentioned in the sources.
In the chat it was mentioned that Wonder had already done some work on the SWOT analysis. Please note that we had no access to previous work done on the company, therefore, it is not certain if insights or sources were duplicated.